Updates matching "National"

Statement from ACS and ACS CAN CEO Karen E. Knudsen on the announcement NCI Director Monica Bertagnolli has been diagnosed with breast cancer.

WASHINGTON, D.C.—December 8, 2022 —The costs of being diagnosed with cancer last long after the diagnosis and initial treatment putting cancer survivors at increased risk for lifelong financial hardship, according to a new report from the American Cancer Society Cancer Action Network (ACS CAN). The report, The Costs of Cancer

The U.S. Senate voted today on legislation that would help ensure marriage equality for same-sex and interracial couples and their families, as well as protect their ability to access employment benefits, such as health insurance.

WASHINGTON, D.C.—Today House Speaker Nancy Pelosi announced she will not seek re-election to Democratic leadership. In response, American Cancer Society Cancer Action Network President Lisa Lacasse issued the following statement: “In the combined decade Speaker Pelosi has presided over the U.S. House of Representatives, she has played a key role

Cancer advocates are urging Congress to prioritize cancer prevention, detection, research and palliative care in any forthcoming year-end legislative package as a way to accelerate progress against the disease and end cancer as we know it.

Washington, D,C. – The American Cancer Society Cancer Action Network (ACS CAN) and its partners submitted an amicus curiae (or friend-of-the-court) brief today in support of the U.S. Food and Drug Administration’s marketing denial order (MDO) for Logic Technology Development’s menthol flavored e-cigarettes. Logic’s menthol e-cigarette is the first menthol-flavored

New data from the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention’s (CDC) National Youth Tobacco Survey (NYTS) finds more than 3 million youth report current use (past 30 days) of any tobacco product in 2022.

The U.S. Court of Appeals for the Third Circuit ruled in favor of the U.S. Food and Drug Administration (FDA) in the case of Liquid Labs LLC v. FDA, upholding the agency’s marketing denial order (MDO) for Liquid Lab’s flavored e-cigarette products.